into Life Science software corporation is a joint venture between iNNiData Corp., USA, and up to data, Germany. The two companies joined forces in 2020 to better be able to serve the needs of the life sciences industry. Following FDA, NMPA, and EMA Rules and Regulations and industry best practices, our study document generation and data review products support preclinical, clinical trials and related activities for both regulated and unregulated bioanalysis, immunogenicity, and biomarkers. Our products are also 21 CFR Part 11 compliant per the FDA’s regulations for electronic documentation, electronic signatures, and human-readable archiving. With over 30 years of combined experience providing innovative solutions in the life sciences arena, we’ve already become the leaders in providing solutions for automated creation of study documentation and review for the pharmaceutical, agroscience, and biotech sciences.